Find Clinical and Medical Trials for Hepatitis C

<< Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next >>

Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection - 9120
The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin - 9168
Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-Infected Patients - 9226
Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients - 9258
Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV co-Infected Subjects vs Baseline Liver Biopsy Metavir Score - 9275
Efficacy of Pegylated Interferon on Liver Fibrosis in co-Infected Patient With HIV and Hepatitis C - 9302
HIV and Hepatitis Care Coordination in Methadone Treatment - 9347
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy - 9354
Treatment of Hepatitis C in Hemophilic Patients With HIV - 9449
A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) - 9478
Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV co-Infected Patients - 9552
Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) - 9558
Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients - 9574
Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy - 9641
An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C - 9653

<< Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next >>